Pfizer and its partner, BioNTech, have officially submitted data to the U.S. Food and Drug Administration (FDA) to have its vaccine authorized for use in children aged six months to four years old.
The company announced the move on Tuesday afternoon, following reports earlier in the day that the regulatory agency was urging them to submit an application soon.
Despite the push from regulators to expand eligibility for the shots to include young children, the move would be controversial and would also make the U.S. the only nation in America to jab children under one years old for Covid.
It would also make the U.S. the world’s lone nation to approve the Pfizer vaccine for children under five, and some doubt the shot is needed for people that young due to the little risk they suffer from the virus.
Source: | This article originally belongs to Dailymail.co.uk
Source: Sound Health and Lasting Wealth
